Position in CHRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,188,604
-$680,198 QoQ
Shares Held
1,886,748
-30.7% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TANG CAPITAL MANAGEMENT LLC holds $1,792,526,680 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
13,044,106 | $221,358,478 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
1,892,200 | $167,989,516 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,236,027 | $144,701,680 | |
| 4 | CELC |
Celcuity Inc.
|
1,314,594 | $137,532,824 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
1,500,000 | $130,425,000 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
1,500,000 | $122,355,000 | |
| 7 | LKFT |
Lakefront Biotherapeutics NV
|
3,785,991 | $113,504,010 | |
| 8 | CAPR |
Capricor Therapeutics, Inc.
|
4,099,900 | $98,725,592 |
All Filings in CHRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,188,604 | 1,886,748 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $3,868,802 | 2,724,509 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,359,673 | 5,097,362 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,726,171 | 5,097,362 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $4,113,571 | 5,097,362 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $5,037,000 | 3,650,000 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,444,000 | 2,350,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,816,500 | 1,050,000 | Shares | Other | 2024-08-14 | |
| 2023-09-30 | $1,496,000 | 400,000 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $1,708,000 | 400,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,368,000 | 200,000 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $917,928 | 115,900 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $7,207,500 | 750,000 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $5,430,000 | 750,000 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $9,682,500 | 750,000 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $10,374,000 | 650,000 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $10,445,500 | 650,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $8,989,500 | 650,000 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $9,496,500 | 650,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $11,297,000 | 650,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $10,087,000 | 550,000 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $9,823,000 | 550,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $5,677,000 | 350,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||